Balentine LLC’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-28,257
Closed -$2.73M 438
2024
Q1
$2.73M Buy
28,257
+518
+2% +$53.1K 0.08% 81
2023
Q4
$2.8M Buy
27,739
+2,699
+11% +$261K 0.09% 79
2023
Q3
$2.55M Buy
25,040
+5,814
+30% +$590K 0.09% 72
2023
Q2
$1.94M Buy
19,226
+68
+0.4% +$6.8K 0.06% 92
2023
Q1
$1.76M Buy
19,158
+2,151
+13% +$188K 0.06% 103
2022
Q4
$1.54M Buy
17,007
+2,337
+16% +$197K 0.05% 128
2022
Q3
$1.11M Sell
14,670
-5,092
-26% -$422K 0.04% 142
2022
Q2
$1.67M Buy
19,762
+9,090
+85% +$797K 0.06% 135
2022
Q1
$936K Buy
10,672
+3,538
+50% +$306K 0.03% 182
2021
Q4
$624K Buy
7,134
+1,659
+30% +$138K 0.02% 141
2021
Q3
$448K Buy
5,475
+336
+7% +$30.2K 0.02% 131
2021
Q2
$469K Buy
5,139
+414
+9% +$36.9K 0.02% 88
2021
Q1
$404K Buy
4,725
+432
+10% +$38.8K 0.02% 87
2020
Q4
$405K Buy
4,293
+685
+19% +$59.9K 0.02% 79
2020
Q3
$314K Buy
3,608
+1,205
+50% +$104K 0.02% 92
2020
Q2
$210K Buy
+2,403
New +$207K 0.01% 96
2019
Q4
Sell
-993
Closed -$86K 701
2019
Q3
$86K Hold
993
0.01% 106
2019
Q2
$91K Buy
993
+58
+6% +$4.91K 0.01% 72
2019
Q1
$81K Hold
935
0.01% 99
2018
Q4
$72K Buy
935
+600
+179% +$46.7K 0.01% 99
2018
Q3
$26K Buy
+335
New +$24.8K ﹤0.01% 116
2018
Q1
Sell
-305
Closed -$23K 379
2017
Q4
$23K Hold
305
﹤0.01% 366
2017
Q3
$23K Sell
305
-20
-6% -$1.51K ﹤0.01% 372
2017
Q2
$24K Buy
325
+16
+5% +$1.13K ﹤0.01% 349
2017
Q1
$21K Sell
309
-18
-6% -$1.2K ﹤0.01% 342
2016
Q4
$21K Buy
327
+84
+35% +$5.45K ﹤0.01% 320
2016
Q3
$17K Buy
243
+68
+39% +$4.96K ﹤0.01% 296
2016
Q2
$13K Hold
175
﹤0.01% 307
2016
Q1
$11K Sell
175
-71
-29% -$4.83K ﹤0.01% 245
2015
Q4
$19K Sell
246
-158
-39% -$12.6K ﹤0.01% 257
2015
Q3
$33K Buy
404
+119
+42% +$10.6K 0.01% 225
2015
Q2
$25K Buy
285
+13
+5% +$1.19K ﹤0.01% 243
2015
Q1
$24K Buy
+272
New +$24.1K ﹤0.01% 226

Other funds holding NVS